| | | Single nucleotide variant (non-coding transcript variant +1 more) | Complement component 5 deficiency +2 more | |
| | C5, C5-OT1 (I1677V +1 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +3 more | |
| | C5, C5-OT1 (E1675K +1 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +3 more | |
| | | Single nucleotide variant (missense variant) | Eculizumab, poor response to +2 more | |
| | | Single nucleotide variant (missense variant) | Eculizumab, poor response to +2 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +2 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +2 more | |
| | | Single nucleotide variant (intron variant) | not specified +3 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | Complement component 5 deficiency +3 more | |
| | | Single nucleotide variant (splice acceptor variant) | Eculizumab, poor response to +2 more | |
| | | Single nucleotide variant (missense variant) | Complement component 5 deficiency +1 more | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Single nucleotide variant (intron variant) | Eculizumab, poor response to +2 more | |
| | | Single nucleotide variant (missense variant) | Eculizumab, poor response to +2 more | |
| | | Single nucleotide variant (nonsense) | Complement component 5 deficiency +2 more | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | Eculizumab, poor response to +2 more | |
| | | Single nucleotide variant (missense variant) | Complement component 5 deficiency +2 more | |
| | | Single nucleotide variant (intron variant) | Complement component 5 deficiency +2 more | |
| | | Single nucleotide variant (synonymous variant) | Eculizumab, poor response to +1 more | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Single nucleotide variant (intron variant) | not provided +2 more | |
| | | Single nucleotide variant (intron variant) | Eculizumab, poor response to +2 more | |
| | | Single nucleotide variant (missense variant) | Complement component 5 deficiency +2 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Complement component 5 deficiency +2 more | |
| | | Single nucleotide variant (missense variant) | not provided +3 more | |
| | | Single nucleotide variant (intron variant) | Complement component 5 deficiency +2 more | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | not specified +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Complement component 5 deficiency +2 more | |
| | | Single nucleotide variant (intron variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | Complement component 5 deficiency +2 more | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | Complement component 5 deficiency +3 more | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | Eculizumab, poor response to +2 more | |
| | | Single nucleotide variant (intron variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Single nucleotide variant (synonymous variant) | Eculizumab, poor response to +2 more | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Indel (intron variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | Eculizumab, poor response to +2 more | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | Complement component 5 deficiency +2 more | |
| | | Single nucleotide variant (synonymous variant) | Eculizumab, poor response to +2 more | |
| | | Single nucleotide variant (splice donor variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | Complement component 5 deficiency +2 more | |
| | | Single nucleotide variant (missense variant) | not specified +3 more | |
| | | Single nucleotide variant (intron variant) | Complement component 5 deficiency +3 more | |
| | | Single nucleotide variant (intron variant) | not provided +2 more | |
| | | Single nucleotide variant (intron variant) | not provided +2 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | Eculizumab, poor response to +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Complement component 5 deficiency +2 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +2 more | |
| | | Single nucleotide variant (intron variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | Eculizumab, poor response to +2 more | |
| | | Single nucleotide variant (intron variant) | Eculizumab, poor response to +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | not provided +2 more | |
| | | Single nucleotide variant (synonymous variant) | Complement component 5 deficiency +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Single nucleotide variant (intron variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | not specified +3 more | |
| | | Single nucleotide variant (missense variant) | Complement component 5 deficiency +2 more | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Single nucleotide variant (nonsense) | not provided +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Eculizumab, poor response to +2 more | |
| | | Single nucleotide variant (synonymous variant) | not specified +3 more | |
| | | Single nucleotide variant (synonymous variant) | Eculizumab, poor response to +2 more | |
| | | Single nucleotide variant (intron variant) | Eculizumab, poor response to +2 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +2 more | |
| | | Single nucleotide variant (synonymous variant) | Eculizumab, poor response to +2 more | |
| | | Single nucleotide variant (synonymous variant) | Complement component 5 deficiency +3 more | |
| | | Single nucleotide variant (missense variant) | Complement component 5 deficiency +2 more | |
| | | Single nucleotide variant (missense variant) | Eculizumab, poor response to +2 more | |
| | | Single nucleotide variant (synonymous variant) | Complement component 5 deficiency +2 more | |
| | | Single nucleotide variant (missense variant) | Eculizumab, poor response to +2 more | |
| | | Single nucleotide variant (missense variant) | Eculizumab, poor response to +2 more | |
| | | Single nucleotide variant (intron variant) | Complement component 5 deficiency +2 more | |
| | | Single nucleotide variant (synonymous variant) | Eculizumab, poor response to +2 more | |
| | | Single nucleotide variant (intron variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | Eculizumab, poor response to +2 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +2 more | |
| | | Single nucleotide variant (synonymous variant) | Complement component 5 deficiency +2 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +2 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | Complement component 5 deficiency +2 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +3 more | |
| | | Single nucleotide variant (missense variant) | Complement component 5 deficiency +2 more | |
| | | Single nucleotide variant (nonsense +1 more) | not provided +3 more | |